Further education in psychedelic-assisted therapy - experiences from Switzerland.
BMC medical education March 5, 2025 H D Aicher, F Müller, P Gasser 11 citations
Demand for specialized training in psychedelic-assisted therapy (PAT) in Switzerland far exceeds supply, and this gap is expected to widen as psychedelics potentially become regulated prescription medications. Since 2014, MDMA, psilocybin, and LSD have been available under limited medical use as exceptional treatments. The Swiss Medical Association for Psychedelic Therapy (SÄPT) offers a comprehensive three-year training program for physicians and psychologists that integrates theoretical knowledge with hands-on experience, emphasizing the therapeutic relationship, ethical considerations, and managing altered states of consciousness. Several organizations have expanded educational offerings, including workshops, conferences, and symposia. Establishing certification standards and ensuring training quality are essential for safe and effective PAT.